{"schema_version":"1","generated_at":"2026-11-17T07:31:39.159Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sandra-algaze","json_url":"https://www.findmykol.com/kol/sandra-algaze/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sandra-algaze","name":"Sandra Algaze","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Southern California","institution_url":"https://www.findmykol.com/institution/university-of-southern-california","city":"Los Angeles","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1861886707","orcid":"0000-0001-7233-5019","openalex":"A5060361217"},"summary":"Sandra Algaze is an Oncology physician affiliated with University of Southern California. OpenAlex indexes 111 publications with 321 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":111,"cited_by_count":321,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":15,"program_years":{"first":2021,"last":null},"rows_total":22,"shown":3,"withheld":19,"rows":[{"payer":"Takeda","program_year":2025,"amount_usd":61394.57,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861886707"},{"payer":"AbbVie","program_year":2025,"amount_usd":30015,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861886707"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":3780,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861886707"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1861886707","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":54.9,"classes_total":5,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":12.3,"drugs":[{"name":"Ondansetron Odt","share_pct":100}],"max_beneficiaries":14},{"class":"Corticosteroid","setting":"prescribed","share_pct":11.5,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":26.2,"classes_total":2,"classes":[{"class":"Loop diuretic","setting":"prescribed","share_pct":17.2,"drugs":[{"name":"Furosemide","share_pct":100}],"max_beneficiaries":11},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":9,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":9.8,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":9.8,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":4,"facility_pct":96},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"A randomized phase II trial of gemcitabine, nab‐paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer","year":2026,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.70343","status":"verified"},{"title":"Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics","year":2026,"journal":"American Society of Clinical Oncology Educational Book","source_url":"https://doi.org/10.1200/edbk-26-516576","status":"verified"},{"title":"Pyroptosis and gasdermin expression in metastatic colorectal cancer.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.211","status":"verified"},{"title":"Decoding molecular, clinico-pathological, and outcome differences between early-onset (EO, <50 years) and late-onset (LO, ≥50 years) mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) colorectal cancer (CRC): Insights from real-world data.","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.19","status":"verified"},{"title":"Predictive and prognostic role of protease-activated receptors (PARs) in colorectal cancer (CRC).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.2_suppl.213","status":"verified"}],"source":"works"},"contact":{"address_1":"1441 EASTLAKE AVE","city":"Los Angeles","state":"CA","zip":"900891005","phone":"323-865-3000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1861886707","source":"identity"},"similar":[{"name":"David Liebeskind","slug":"david-liebeskind","institution":"University of Southern California","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-liebeskind","json_url":"https://www.findmykol.com/kol/david-liebeskind/profile.json"},{"name":"Siamak Daneshmand","slug":"siamak-daneshmand","institution":"University of Southern California","specialty":"Urology","url":"https://www.findmykol.com/kol/siamak-daneshmand","json_url":"https://www.findmykol.com/kol/siamak-daneshmand/profile.json"},{"name":"David Freyer","slug":"david-freyer","institution":"University of Southern California","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/david-freyer","json_url":"https://www.findmykol.com/kol/david-freyer/profile.json"},{"name":"Andrew Moshfeghi","slug":"andrew-moshfeghi","institution":"University of Southern California","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/andrew-moshfeghi","json_url":"https://www.findmykol.com/kol/andrew-moshfeghi/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":19,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-12-08","provider_certified":"2021-12-08","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}